Activating killer cell Ig-like receptors in health and disease.
about
Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?Newtonian cell interactions shape natural killer cell educationEmerging role of Natural killer cells in oncolytic virotherapyHarnessing adaptive natural killer cells in cancer immunotherapyAssociation of HLA class-I and inhibitory KIR genotypes in Gabonese patients infected by Chikungunya or Dengue type-2 viruses.A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia.The Size of Activating and Inhibitory Killer Ig-like Receptor Nanoclusters Is Controlled by the Transmembrane Sequence and Affects SignalingKIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors.Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology.NK Cells: Uncertain Allies against Malaria.Modulation of Human Leukocyte Antigen-C by Human Cytomegalovirus Stimulates KIR2DS1 Recognition by Natural Killer Cells.KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing.Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.Risk stratification and immunogenetic risk for infections following stem cell transplantationKIR, LILRB and their Ligands' Genes as Potential Biomarkers in Recurrent Implantation Failure.Peptide-specific engagement of the activating NK cell receptor KIR2DS1.Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients.KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C.NK receptors: tools for a polyvalent cell family.KIR3DS1/HLA-B Bw4-80Ile Genotype Is Correlated with the IFN-α Therapy Response in hepatitis B e antigen-Positive Chronic Hepatitis B.Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment.HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance.Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double-blind, placebo-controlled clinical trial.KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.Genotype B of Killer Cell Immunoglobulin-Like Receptor is Related with Gastric Cancer Lesions.
P2860
Q26776114-2A96C15B-A966-43E1-89B5-E24FB606BB45Q26797240-01F92C97-D6E1-42BC-AB5D-E667E67D2D4DQ27025330-F407129E-5F02-48BC-B94A-C72A993A4899Q28081448-0E975C4F-549A-4BE9-B13A-60CF5B8826DFQ34275095-E07AAD85-A7A7-4F79-A653-83DB6D0BD605Q35031374-AAB85551-0071-4E56-9D44-CBBB31190174Q36025742-B832F7BF-C6D0-4B18-BDEF-0AEC4CC94237Q37471733-5B42899E-0A4A-4114-A20D-A92F7523CF6CQ37622486-E16AF9ED-66F3-430B-84A2-8D34D147B8D2Q37689434-F6B11230-A659-4542-AE9C-EEE1333D78E5Q37729495-43E77965-DBF1-4CA3-9159-497EAFDEFCD2Q38731024-E138B668-FBF3-46AB-9A30-43889DBE87EEQ38772230-CC54AE4F-4B83-42FE-B84B-78DC54FF2683Q38950315-D4634BE6-8EE2-42C5-B408-2EE75A0B72AAQ39317288-3BF467DF-7F17-4E82-93B3-9014643F31A1Q40184605-4345409A-ADB1-460A-8D56-AEEF4BD21212Q40260933-88561E59-AB36-44BE-AC4B-4842FE5C14BBQ41930029-B0FDB136-2419-4738-8CEB-AD96661D9A3EQ42122048-8DA8F31E-52CD-4026-92BD-B9258C16FDB8Q42700237-47DD502F-D907-435A-8018-E4D59B17FBC5Q43185293-F6146BE4-47B9-4EBC-A2B8-2E45656A2E7AQ47554124-A9C278BE-4DB6-46C2-BFD6-23A74777D482Q47564469-00EBBF65-7220-4EBF-A2BB-08E9EA78BAD7Q49884471-0DAE5FFD-5C85-44AF-A5B0-D7A14751F2A0Q51725094-7712E0AF-33FC-44EE-B153-08C7CEF318C3Q55154779-142DDEC9-D58C-451C-8FFC-292AE0773960
P2860
Activating killer cell Ig-like receptors in health and disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activating killer cell Ig-like receptors in health and disease.
@en
Activating killer cell Ig-like receptors in health and disease.
@nl
type
label
Activating killer cell Ig-like receptors in health and disease.
@en
Activating killer cell Ig-like receptors in health and disease.
@nl
prefLabel
Activating killer cell Ig-like receptors in health and disease.
@en
Activating killer cell Ig-like receptors in health and disease.
@nl
P2860
P356
P1476
Activating killer cell Ig-like receptors in health and disease.
@en
P2093
Jakob Michaëlsson
Martin A Ivarsson
P2860
P356
10.3389/FIMMU.2014.00184
P577
2014-04-22T00:00:00Z